|
|
TTD Drug ID:
DNC001626
Drug
Information |
Name | Dilazep | Indication | Not Available | Experimental | Structure |
Click to save drug structure in 3D MOL format
Click to save drug structure in 2D MOL format
| InChI | 1S/C31H44N2O10/c1-36-24-18-22(19-25(37-2)28(24)40-5)30(34)42-16-8 -12-32-10-7-11-33(15-14-32)13-9-17-43-31(35)23-20-26(38-3)29(41-6 )27(21-23)39-4/h18-21H,7-17H2,1-6H3 | InChIKey | QVZCXCJXTMIDME-UHFFFAOYSA-N | Canonical SMILES | COC1=CC(=CC(=C1OC)OC)C(=O)OCCCN2CCCN(CC2)CCCOC(=O)C3=CC(=C(C(=C3)OC)OC) OC | PubChem Compound ID | CID 3074. | PubChem Substance ID | SID 178692. | SuperDrug ATC ID | C01DX10 | C01DX10 | Target | Equilibrative nucleoside transporter 1 |  | Inhibitor | [1] | Ref 1 | Residues Met89 and Ser160 in the human equilibrative nucleoside transporter 1 affect its affinity for adenosine, guanosine, S6-(4-nitrobenzyl)-mercaptopurine riboside, and dipyridamole. Mol Pharmacol. 2005 Mar;67(3):837-44. Epub 2004 Nov 19. To Reference |
Welcome
to sign our Guestbook.
If you
find any error in data or bug in web service, please kindly report it
to Dr.
Zhu.
Dr.
Chen Yuzong
Deputy Director of Center
for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore
All rights reserved.
|